In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • A new study led by Dr. Stacy Gray and Dr. Katherine Janeway showed online marketing for products related to personalized cancer medicine often failed to explain the limits of the genetic tests.

Tags: Genomics

  • Dr. Barrett Rollins commented in The Journal of the American Medical Association about how precision medicine has helped patients at Dana-Farber.

Tags: Genomics, TargetedTherapy

  • Dr. Rachel Freedman led a study that found many women with breast cancer may lack knowledge regarding their illness. The findings show how minority patients may be less likely than others to know and report accurate information about their tumors' characteristics.

Tags: PatientEducation, PatientSupport

  • Dr. Stephen Sallan received the Pediatric Oncology Award and Lecture as part of the American Society of Clinical Oncology Special Awards Program, which recognizes achievements in the field of pediatric oncology.

Tags: ChildhoodCancer

  • Dr. Edward J. Benz, Jr., was part of a panel discussion that followed the preview screening of the film, “Cancer: The Emperor of All Maladies,” which features Dr. Stephen Sallan and Dr. David Nathan, as well as segments focused on Dr. Sidney Farber and the Jimmy Fund.

Tags: PatientEducation, PatientSupport

  • Dr. Ann Partridge helped launch a new app, called ResearchKit, part of Apple's mobile health program.  The app will allow researchers to access data from breast cancer survivors to provide improved post-treatment quality of life.

Tags: BreastCancer

  • Dr. Joseph Antin commented on the rising number of patients seeking bone marrow transplants and the demand it has created on registries that match patient needs with willing donors.

Tags: Leukemia, CopingWithCancer

  • Dr. Kimberly Stegmaier contributed to an editorial urging Congress to fund precision medicine research.

  • Dr. Stacy Gray and Dr. Katherine Janeway studied websites offering products or services related to "personalized cancer medicine." Their research showed online marketing to consumers often failed to explain the limits of the genetic tests.

Tags: Genomics, Genetics

  • Dr. Harold Burstein commented on a new study that found among women with operable hormone-receptor-negative breast cancer, who were given goserelin (Zoladex) in addition to chemotherapy, had lower rates of ovarian failure and higher rates of pregnancy compared with patients treated with chemotherapy alone.

Tags: BreastCancer

Showing 11-20 of 534 items